ADMA Biologics, Inc. (ADMA)

16.24 -0.08 (-0.49%) USD  |  NASDAQ  |  Feb 20, 12:54
More

ADMA Biologics Underperform Recommendations

Underperform Recommendations Chart

View Underperform Recommendations for ADMA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Underperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Underperform Recommendations Range, Past 5 Years

View Underperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Underperform Recommendations Benchmarks

View Underperform Recommendations Benchmarks
Start Trial
Arcutis Biotherapeutics, Inc. Upgrade
Marker Therapeutics, Inc. Upgrade
CorMedix, Inc. Upgrade
Viridian Therapeutics, Inc. Upgrade
Editas Medicine, Inc. Upgrade